The role of HIV research in building health system capacity in developing countries

Current Opinion in HIV and AIDS

Volumn 3, Issue 4, 2008, Pages 481-488

  Zewdie, Debrework ^a   Cahn, Pedro ^b   McClure, Craig ^c   Bataringaya, Jacqueline ^c   Bennett, Karen ^c  

^a WORLD BANK   (United States)

^b FUNDACIÓN HUÉSPED   (Argentina)

^c UNAIDS   (Switzerland)

Author keywords

Capacity building; Health system; HIV research; Scale up

Indexed keywords

COTRIMOXAZOLE;

CLINICAL RESEARCH; COMMUNITY CARE; COST EFFECTIVENESS ANALYSIS; DEVELOPING COUNTRY; EVALUATION; HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; HEALTH CARE SYSTEM; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFORMATION; LEADERSHIP; MONITORING; NATIONAL HEALTH SERVICE; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW;

EID: 67649574155     PISSN: 1746630X     EISSN: 17466318     Source Type: Journal    
DOI: 10.1097/COH.0b013e328304382a     Document Type: Review

References (59)

1. UNAIDS and WHO. 2007 AIDS Epidemic Update. December 2007. http://data.unaids.org/pub/EPISlides/2007/2007-epiupdate-en.pdf. [Accessed 17 April 2008]
2. Report of the Commission on Macroeconomics and Health. Macroeconomics and Health: Investing in Health for Economic Development. World Health Organization. Presented by Jeffrey D. Sachs to Gro Harlem Bruntland. 20 December 2001. Geneva: WHO; 2001.
3. Feacham RGA. The research imperative: fighting AIDS, TB and malaria. Trop Med Int Health 2004; 9:1139-1141.
4. th meeting of the World Health Assembly.2005.http://www.who.int/rpc/meetings/58th-WHA-resolution.pdf. [Accessed 17 April 2008]
5. Report from the Ministerial Summit on Health Research. Identify challenges, inform actions, correct inequities.Co-organized and co-sponsored by World Health Organization and Government of Mexico. Mexico City. 16-20 November 2004. http://www.who.int/rpc/summit/documents/summit-report-final2.pdf. [Accessed 17 April 2008]
6. th IAS Conference on Pathogenesis, Treatment and Prevention. 22-25 July 2007, Sydney. Geneva: IAS; 2004.
7. PEPFAR. The Power of Partnerships: Fourth Annual Report to Congress on PEPFAR. 2008. http://www.pepfar.gov/documents/organization/100029.pdf. [Accessed 17 April 2008]
8. Alliance for Health Policy and Systems Research. Strengthening health systems in developing countries: the promise of researchon policy and systems. Geneva: Alliance for Health Policy and Systems Research; 2004. http://www.who.int/alliance-hpsr/resources/Strengthening-complet.pdf. [Accessed 17 April 2008]
9. Bennett S, Boerna T, Brugha R. Scaling up HIV/AIDS evaluation. Lancet 2006; 367:79-82.
10. Hirschhorn LR, Ojikutu B, Rodriguez W. Research for change: using implementation research to strengthen hiv care and treatment scale-up in resourcelimited settings. J Infect Dis 2007; 196 (Suppl 3):516-522. This article presents strong arguments for research to strengthen scale-up of HIV care and treatment in resource-limited settings. It is an excellent review of current understanding of the field of implementation research and discusses its association with other areas of health services research, clinical research, and quality management work. It also highlights opportunities and next steps for conducting implementation research.
11. Zachariah R, Harries AD, Luo C, Bachman G, et al. Scaling-up co-trimoxazole prophylaxis in HIV-exposed and HIV-infected children in high HIV-prevalence countries. Lancet Infect Dis 2007; 7:686-693. This review is an excellent example of research needed to generate knowledge and inform policy development for system-wide scaling up of benefits of clinical research. This article discusses some of the major barriers, including health system constraints, preventing the scale up of co-trimoxazole prophylaxis for children in countries with high prevalence of HIV and proposes specific actions required to tackle these challenges.
12. Zachariah D, Fitzgerald M, Massaquoi M, Acabu A, et al. Does antiretroviral treatment reduce case fatality among HIV-positive patients with tuberculosis in Malawi. Int J Tuberc Lung Dis 2007; 11:848-853. This article sets forth a comparative analysis of treatment outcomes for tuberculosis patients registered in 2004 in the Thyolo district, Malawi. It shows that ART provided in the continuation phase of tuberculosis treatment does not have a significant impact on reducing case fatality.
13. Zachariah D, Fitzgerald M, Massaquoi M, Pasulani O, et al. Risk factors for high early mortality in patients on antiretroviral treatment in a rural district of Malawi. AIDS 2006; 20:2355-2360.
14. Sanders D, Haines A. Implementation research is needed to achieve international health goals. PLOS Med 2006; 3:e186.
15. World Health Organization. Expanding capacity for operations research in reproductive health: summary report of a consultative meeting. Geneva: WHO. 10-12 December 2001. http://www.who.int/reproductive-health/docs/expanding- capacity.pdf. [Accessed 17 April 2008]
16. World Health Organization. Summary of activities. Evidence to improve HIV treatment and prevention programs: operational research to support HIV treatment and prevention in resource-limited settings. July 2004-January 2006. Geneva: WHO; 2006.
17. Hirschhorn LR. Ensuring quality of care in the scale-up of HIV care and treatment in resource-limited settings: a challenge for all. Future Medicine 2007; 4:737-744. This article presents current thinking on the need to expand and strengthen quality assurance and quality research in the scale-up of HIV care and treatment in resource-limited settings. The discussion brings the field of measuring and improving quality to the different disciplines engaged in HIV scale-up efforts, and outlines key areas that need to be addressed to improve programme efficacy, decrease risk of drug resistance and promote optimal use of existing resources including personnel and drugs.
18. Mashauri FM, Siza JE, Temu MM, et al. Assessment of quality assurance in HIV testing in health facilities in Lake Victoria zone, Tanzania. Tanzan Health Res Bull 2007; 9:110-114.
19. UNAIDS. Financial resources required to achieve universal access to HIV prevention, treatment, care and support. 26 September 2007. http://data.unaids. org/pub/Report/2007/20070925-advocacy-grne2-en.pdf. [Accessed 17 April 2008]
20. Chisholm D, Evans DB. Economic evaluation in health: saving money or improving care? Journal of Medical Economics 2007; 10:325-337. This policy review studies the appropriate role and use of cost-effectiveness analysis within the context of health system financing. The authors conclude that, beyond the purpose of addressing the health-financing objective of efficiency, economic evaluation can be usefully extended to other health system goals, between which financial protection and equity in financing, by adopting a sectoral or population-based approach.
21. Pitter C, Kahn JG, Marseille E, Lule JR, et al. Cost-effectiveness of cotrimoxazole prophylaxis among persons with HIV in Uganda. J Acquir Immune Defic Syndr 2007; 44:336-343. This study analysed the cost-effectiveness of daily co-trimoxazole prophylaxis, based on modeling clinical results and operational data from a prospective cohort study of home-based care delivery to adults and children with HIV living in rural Uganda. The study adds to the body of evidence on the beneficial effects on health outcomes and health system demands associated with co-trimoxazole prophylaxis. It critically underscores a highly cost-effective algorithm that maximizes investments and reduces costs compared with other approaches.
22. Goldie SJ, Yazdanpanah Y, Losina E, et al. Cost imeffectiveness of HIV treatment in resource-poor settings: the case of côte d'Ivoire. N Engl J Med 2006; 355:1141-1153.
23. Koenig S, Riviere C, Leger P, Severe P, et al. The cost of antiretroviral therapy in Haiti. Cost Eff Resour Alloc 2008; 6:3. This research determines direct medical costs, overhead costs, societal costs, and personnel requirements for the provision of antiretroviral therapy to patients with AIDS in Haiti. The importance of this research is that it provides empirical evidence required not only for planning andbudgeting national treatment programmes, but also for developing national and international funding projections; developing health system policies to ensure equitable access between urban and rural regions; and evidence for advocacy for increased price reductions for second-line drugs.
24. Kahn JG, Marseille E, Auvert B. Cost-effectiveness of male circumcision for HIV Prevention in a South African Setting. PLOS Med 2006; 3:e517.
25. UNAIDS. "Three Ones" key principles: "Coordination of National Responses to HIV/AIDS" Guiding principles for national authorities and their partners. 25 April 2004. http://data.unaids.org/UNA-docs/Three-Ones- KeyPrinciples-en.pdf. [Accessed 17 April 2008]
26. Garcia-Calleja JM, Zaniewski E, Ghys PD, et al. A global analysis of trends in the quality of HIV sero-surveillance. Sex Transm Inf 2004; 80:30.
27. Walensky RP, Weinstein MC, Yazdanpanah Y, Losina E, et al. HIV Drug resistance surveillance for prioritizing treatment in resource-limited settings. AIDS 2007; 21:973-982.
28. Otwombe KN, Wanyungu J, Nduku K, Taegtmeyer M. Improving national data collection systems from voluntary counseling and testing centres in Kenya. Bull World Health Organ 2007; 85:315-318.
29. World Health Organization. Everybody's business: Strengthening health systems to improve health outcomes, WHO's framework for action. Geneva: WHO; 2007.
30. Task Force on Health Systems Research. Report of the Task Force on Health Systems Research, The Millennium Development Goals will not be attained without new research addressing health system constraints to delivering effective interventions. March 2005. Geneva: WHO; 2005.
31. El-Sadr WM, Abrams EJ. Scale-up of HIV care and treatment: can it transform healthcare services in resource-limited settings? AIDS 2007; 21 (suppl 5): S65-S70. This article presents arguments supporting use of resources available for the scaleup of HIV care and treatment, in the design and implementation of HIV programmes with the additional goal of benefiting the broader health services. The paper highlights ways in which HIV programmes may catalyze the transformation into more effective and responsive health systems capable of addressing other community health needs, and proposes relevant research and evaluation to guide this process.
32. Katabira ET, Oelrichs RB. Scaling-up antiretroviral treatment in resourcelimited settings: successes and challenges. AIDS 2007; 21 (suppl 4):S5-S10. This article presents the current achievements and challenges of scaling up antiretroviral treatment in resource limited settings (Uganda) The study describes successes including increased number of patients on treatment with benefits of easing of HIV burdens on the health system, development of training programmes, rehabilitation of infrastructure, strengthening procurement systems, and reduction of drug prices and other related costs. It also highlights numerous challenges that must still be addressed including retaining capable health-workers, maintaining patient adherence to minimize drug resistance, sustaining drug procurement/supplies, and building health systems.
33. Mexican National Institute of Public Health (INSP), Clinton Foundation HIV/AIDS Initiative (CHAI). ARV demand forecast: 2007-2008. Geneva, 11 December 2007. http://www.who.int/hiv/amds/ARVDemandForecastINSP-CHAI.pdf. [Accessed 17 April 2008]
34. Mermin J, Were W, Ekwaru JP, et al. Mortality in HIV-infected Ugandan adults receiving antiretroviral treatment and survival of their HIV-uninfected children: a prospective cohort study. Lancet 2008; 371:752-759. This article presents the results of a prospective cohort study that investigated the effect of a home-based ART programme in Uganda on mortality, hospital admissions and orphanhood in people with HIV-1 and their household members. It concludes that the expansion of access to ART and co-trimoxazole prophylaxis could substantially reduce mortality and orphanhood among adults with HIV and their families living in resource-poor settings.
35. Keshavjee S, Seung K, Satti H, et al. Building capacity for multidrug resistant tuberculosis treatment: health systems strengthening in Lesotho. Innovations: Technology, Governance, Globalization 2007; 2:87-106. The article presents the experience of a multidrug resistance tuberculosis treatment programme in Lesotho. After a general overview of the drug-resistant tuberculosis issue, this case exemplifies a programme whose aims are to address the epidemic, to build capacity in the health sector through close integration with national government, to reduce limitations in infrastructures and structural barriers to care and to set the foundation for nationwide treatment expansion.
36. Partners in Health Bulletin. Autumn 2007. http://www.pih.org/ inforesources/newsletters/PIH-Newsletter-2007Autumn.pdf. [Accessed 17 April 2008]
37. Bekker LG, Myer L, Orrell C, et al. Rapid scale-up of a community-based HIV treatment service: Programme performance over 3 consecutive years in Guguletu, South Africa. S Afr Med J 2006; 96:315-320.
38. Gilks CF, Crowley S, Ekpini R, Gove S, et al. The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings. Lancet 2006; 368:505-510.
39. McPake B. AIDS and human capacity in the health sector. Edinburgh: Institute for International Health & Development (IIHD), Queen Margaret University; 2007.
40. Barnighausen T, Bloom D, Humair S. Human resources for treating HIV/AIDS: needs, capacities and gaps. AIDS Patient Care STDS 2007; 21:799-812. This research uses a discrete-time model to project the human resources gap for universal ART coverage in 10 years. The study draws attention to the compounding role of increased survival probability of treated patients, on existing factors including HIV incidence, health workforce education, emigration and death. A key policy issue raised is the sustained demand and flow of health workers into ART programmes and its potential negative impact on provision of other health services.
41. Damme WV, Kheang ST, Janssens B, Kober K. How labour intensive is a doctor-based delivery model for antiretroviral treatment (ART)? Evidence from an observational study in Siem Reap, Cambodia. Hum Resour Health 2007; 5:12.
42. Muula AS, Chipeta J, Siziya S, Rudatsikira E, et al. Human resources requirements for highly active antiretroviral therapy scale-up in Malawi. BMC Health Serv Res 2007; 7:208.
43. WHO, HIV/AIDS Programme. Task shifting to tackle health worker shortages. 2007.http://www.who.int/healthsystems/task-shifting-booklet.pdf. [Accessed 17 April 2008]
44. Miles K, Clutterbuck DJ, Seitio O, et al. Antiretroviral treatment roll-out in a resource-constrained setting: capitalizing on nursing resources in Botswana. Bull World Health Organ 2007; 85:555-560. This article highlights the importance of capitalizing on nursing and nonphysician resources in antiretroviral treatment scale-up in resource-constrained settings.
45. McCarthy EA, O'Brien M, Rodriguez WR. Training and HIV-treatment scaleup: establishing an implementation research agenda. PLOS Med 2006; 3Le304.
46. Bhan A, Singh JA, Upshur EG, et al. Grand challenges in global health: engaging civil society organizations in biomedical research in developing countries. PLOS Med 2007; 4:e272. This article explores the role of civil society organizations (CSOs) in biomedical research and evaluates the advantages and difficulties of working with them. It stresses that it is in the best interests of science and researchers to work with CSOs to collectively advance the goals of the research programme. It also argues that there is a need for empirical research on best practice models of CSOsresearcher engagements and for evaluation of these models.
47. International Treatment Preparedness Coalition (ITPC). Missing the target 5: improving AIDS Drug Access and Advancing Healthcare for All. December 2007. http://www.aidstreatmentaccess.org/itpc5th.pdf. [Accessed 17 April 2008]
48. Leroy JL, Habicht JP, Pelto G, Bertozzi SM. Current priorities in health research funding and lack of impact on the number of child deaths per year. Am J Public Health 2007; 97:219-223. This paper describes a landmark study on priorities and value for money of health research funding and its impact on health outcomes. It presents strong arguments backed by empirical evidence on the discrepancy between current research and the research needed to save children's lives. This paper discusses a compelling case on the imperative for greater increase in research on delivery and use of technology, over the need to increase research on the efficacy of treatment.
49. Kirigia JM, Wambebe C. Status of national health research systems in ten countries of the WHO African Region. BMC Health Services Research; 19 October 2006. http://www.biomedcentral.com/1472-6963/6/135. [Accessed 17 April 2008]
50. Kuruvilla S, Mays N, Pleasant A, Walt G. Describing the impact of health research: a research impact framework. BMC Health Services Research; 18 October 2006. http://www.biomedcentral.com/1472-6963/6/134. [Accessed 17 April 2008]
51. Van Kerkhoff L, Szlezak N. Linking local knowledge with global action: examining the Global Fund to Fight AIDS, Tuberculosis and Malaria through a knowledge system lens. Bull World Health Organ 2006; 84:629-635.
52. Hanney SR, Gonzalez Block MA. Building health research systems to achieve better health. Health Res Policy Syst 2006; 4:10.
53. Tugwell P, Sitthi-Amorn C, Hatcher-Roberts J, et al. Health research profile to assess the capacity of low and middle income countries for equity-oriented research. BMC Public Health 2006; 6:151.
54. Bates I, Osei Akoto AY, Ansong D, et al. Evaluating health research capacity building: an evidence-based tool. PLOS Med 2006; 3:e299.
55. Rosen S, Fox MP, Gill CJ. Patient retention in antiretroviral therapy programs in Sub-Saharan Africa: a systematic review. PLOS Med 2007; 4:1691-1701. This presents a systematic review of patient retention in ART programmes in sub-Saharan Africa. It presents worrying results that show that close to half of people starting HIV treatment in Africa are no longer receiving treatment after 2 years. These findings have important policy and health system consequences including actions to improve patient tracing procedures, knowledge and understanding of loss to follow-up and earlier initiation of ART. Given what we learn, this study also underscored the need to conduct more systematic reviews across other HIV scale-up issues.
56. Dawad S, Veenstra N. Comparative health systems research in a context of HIV/AIDS: lessons from a multicountry study in South Africa, Tanzania and Zambia. Health Res Policy Syst 2007; 5:13.
57. Reich MR, Takemi K, Roberts MJ, Hsiao WC. Global action on health systems: a proposal for the Toyako G8 Summit. Lancet 2008; 371:865-869.
58. England R. Are we spending too much on HIV? BMJ 2007; 334:344.
59. Behets FMTF, Mtendo R, Vaz LME, et al. Preventing vertical transmission of HIV in Kinshasa, Democratic Republic of the Congo: a baseline survey of 18 antenatal clinics. Bull World Health Organ 2006; 84:969-975.